Inhalation Sciences (ISAB) announced that it intends to replace its CEO. The company intends to announce the name of its new CEO next week. For the present Lena Heffler will continue as the company's CEO. Lena Heffler has asked for leave from her position as CEO on her own initiative, and the Company has already entered into negotiations with her intended successor. The Company intends to announce the name of a new CEO during the coming week. Lena Heffler will remain as the company's CEO for the time being. Following the appointment of the new CEO, she will remain in the Company through her six-month period of notice, focusing on her core key areas of expertise: marketing, sales and project management.